NHI — National Health Investors Income Statement

0.000.00%

Last trade - 00:00

FinancialsConservativeMid CapNeutral

Annual income statement for National Health Investors, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	318	333	299	278	320
Cost of Revenue
Gross Profit	312	323	287	240	269
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	158	166	218	242	201
Operating Profit	160	167	80.7	36.6	119
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	160	185	112	65.5	134
Net Income After Taxes	160	185	112	65.5	134
Minority Interest
Net Income Before Extraordinary Items
Net Income	160	185	112	66.4	136
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	160	185	112	66.4	136
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.75	4.25	2.93	2.23	2.82
Dividends per Share